Hsbc Holdings PLC A Tyr Pharma Inc Transaction History
Hsbc Holdings PLC
- $176 Billion
- Q3 2025
A detailed history of Hsbc Holdings PLC transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 16,139 shares of LIFE stock, worth $30,018. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,139
Previous 24,584
34.35%
Holding current value
$30,018
Previous $45,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LIFE
# of Institutions
120Shares Held
47.5MCall Options Held
1.29MPut Options Held
2.61M-
Federated Hermes, Inc. Pittsburgh, PA10.5MShares$19.6 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$10.5 Million0.0% of portfolio
-
Ubs Group Ag4.51MShares$8.38 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY3.82MShares$7.11 Million2.7% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$4.58 Million1.64% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...